Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

CAR-T Therapy for Lymphoma with Prophylactic Tocilizumab: Decreased Rates of Severe Cytokine Release Syndrome without Excessive Neurologic Toxicity

Paolo F Caimi, MD, Ashish Sharma, Patricio Rojas, MD, Seema Patel, PharmD, Jane Reese, Folashade Otegbeye, MBBChir,MPH, Andrew Worden, Michael Kadan, Michael Maschan, MD PhD, Rimas J Orentas, PhD, Boro Dropulic, PhDMBA, Rafick Sekaly, Marcos de Lima, MD

Blood (2020) 136 (Supplement 1): 30–31.

https://doi.org/10.1182/blood-2020-143114

Published: 2020

Journal Articles

Bruton's Tyrosine Kinase ( BTK ) Is a Novel KMT2A Partner Gene

Elena Zerkalenkova, PhD, Svetlana Lebedeva, Olga Soldatkina, Michael Maschan, MD PhD, Alexey A. Maschan, MD, Galina Novichkova, MD PhD, Yulia Olshanskaya, MD PhD

Blood (2019) 134 (Supplement_1): 5192.

https://doi.org/10.1182/blood-2019-128056

Published: 2019

Journal Articles

Novel KMT2A Partner Gene NUTM2A Revealed By Anchored Multiplex PCR in ALL

Svetlana Lebedeva, Elena Zerkalenkova, PhD, Olga Soldatkina, Michael Maschan, MD PhD, Alexey A. Maschan, MD, Galina Novichkova, MD PhD, Yulia Olshanskaya, MD PhD

Blood (2019) 134 (Supplement_1): 5203.

https://doi.org/10.1182/blood-2019-126602

Published: 2019

Journal Articles

Title Point-of-Care Production of CD19 CAR-T Cells in an Automated Closed-System: Report of First Clinical Experience

Olga Molostova, MD, Larisa Shelikhova, MD, Yakov Muzalevsky, Alexey Kazachenok, Dmitriy Pershin, Elena Kurnikova, Alexander Popov, MD PhD, Boro Dropulic, PhD, Dina Shneider, Rimas Orentas, PhD, Regina Alex, Mike Essl, Natalia Miakova, MD PhD, Dmitry Litvinov, MD PhD, Alexander Karachunskiy, MD PhD, Galina Novichkova, MD PhD, Alexey A. Maschan, MD, Michael Maschan, MD PhD

Blood (2018) 132 (Supplement 1): 5202.

https://doi.org/10.1182/blood-2018-99-118282

Published: 2018

Journal Articles

Replacement of Polyclonal Anti-Thymocyte Globulin By Targeted Immunomodulation Is Associated with Improved Outcome of Alfa\Beta T Cell-Depleted Hematopoietic Stem Cells Transplantation in Children with Acute Leukemia

Blood (2018) 132 (Supplement 1): 481.

https://doi.org/10.1182/blood-2018-99-116007

Published: 2018

Journal Articles

Targeting Bcl-2 and CD38 As Part of Personalized HSCT Conditioning Regimen in Chemorefractory Pediatric Leukemia

Blood (2018) 132 (Supplement 1): 2084.

https://doi.org/10.1182/blood-2018-99-116355

Published: 2018

Journal Articles

T Cell Repertoire after Alpha/Beta-T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients

Ivan Zvyagin, PhD, Olga Tatarinova, Ilgar Mamedov, PhD, Ekaterina Komech, Alexey Maschan, MD PhD, Larisa Shelikhova, MD, Elena Kurnikova, MD, Elena Boyakova, MD, Yuri Lebedev, PhD DSc, Michael Maschan, MD PhD, Dmitry Chudakov, PhD DSc

Blood (2016) 128 (22): 4582.

https://doi.org/10.1182/blood.V128.22.4582.4582

Published: 2016

Journal Articles

Tcrαβ+/CD19+-Depletion in Hematopoietic Stem Cells Transplantation from Matched Unrelated and Haploidentical Donors Following Treosulfan or TBI-Based Conditioning in Pediatric Acute Lymphoblastic Leukemia Patients

Larisa Shelikhova, MD, Zhanna Shekhovtsova, MD, Dmitry Balashov, Elena Boyakova, Iakov Muzalevskyi, Elena Gutovskaya, Irina Shipitsina, Daria Shasheleva, Rimma Khismatullina, Sergey Blagov, Natalia Myakova, Andrey Abrosimov, Galina Novichkova, MD, Alexey Maschan, MD PhD, Michael Maschan, MD PhD

Blood (2016) 128 (22): 4672.

https://doi.org/10.1182/blood.V128.22.4672.4672

Published: 2016

Journal Articles

Relapse Prediction By Flow Cytometric Minimal Residual Disease Assessment in Infants with Acute Lymphoblastic Leukemia

Alexander Popov, MD PhD, Tatiana Verzhbitskaya, Grigory Tsaur, MD PhD, Egor Shorikov, MD PhD, Liudmila Movchan, MD PhD, Mikhail Belevtsev, MD PhD, Anatoly Kustanovich, PhD, Olga Streneva, MD PhD, Olga Khlebnikova, MD, Natalia Myakova, Dmitry Litvinov, MD PhD, Konstantin Kondratchik, MD, Elmira Boychenko, MD PhD, Olga Aleinikova, PhD, Michael Maschan, MD PhD, Alexander Karachunskiy, MD PhD, Larisa Fechina, MD PhD

Blood (2016) 128 (22): 1731.

https://doi.org/10.1182/blood.V128.22.1731.1731

Published: 2016

Journal Articles

Transplantation from Matched Unrelated and Haploidentical Donor in Pediatric Severe Aplastic Anemia: Experience with TCR Alpha/Beta and CD19 Depletion As Graft Processing Method

Daria Shasheleva, Larisa Shelikhova, MD, Zhanna Shekhovtsova, MD, Dmitriy Balashov, Pavel Trakhtman, Elena Boyakova, MD, Elena Raykina, Elena Kurnikova, MD, Alexey Kazachenok, Varvara Briliantova, Anna Bogoyavlenskaya, Maria Ilyushina, Svetlana Kozlovskaya, Galina Novichkova, MD, Michael Maschan, MD PhD, Alexey Maschan, MD PhD

Blood (2016) 128 (22): 2294.

https://doi.org/10.1182/blood.V128.22.2294.2294

Published: 2016

Journal Articles

Improved Control of GvHD with Rabbit ATG, Rituximab and Bortezomib Among Pediatric Leukemia Patients after Tcrαβ/CD19-Depletion of Transplant from Matched Unrelated and Haploidentical Family Donors: A Single-Center Retrospective Analysis of Two Gvhd-Prophylaxis Regimens

Zhanna Shekhovtsova, MD, Larisa Shelikhova, MD, Dmitry Balashov, Elena Kurnikova, MD, Iakov Muzalevskyi, Alexey Kazachenok, Yuliya Skvortsova, Maria Ilyushina, Daria Shasheleva, Rimma Khismatullina, Sergey Blagov, Dmitry Litvinov, MD PhD, Galina Novichkova, MD, Alexey Maschan, MD PhD, Julia Starichkova, Michael Maschan, MD PhD

Blood (2016) 128 (22): 3427.

https://doi.org/10.1182/blood.V128.22.3427.3427

Published: 2016

NARROW

CAR-T Therapy for Lymphoma with Prophylactic Tocilizumab: Decreased Rates of Severe Cytokine Release Syndrome without Excessive Neurologic Toxicity

Bruton's Tyrosine Kinase ( BTK ) Is a Novel KMT2A Partner Gene

Novel KMT2A Partner Gene NUTM2A Revealed By Anchored Multiplex PCR in ALL

Title Point-of-Care Production of CD19 CAR-T Cells in an Automated Closed-System: Report of First Clinical Experience

Replacement of Polyclonal Anti-Thymocyte Globulin By Targeted Immunomodulation Is Associated with Improved Outcome of Alfa\Beta T Cell-Depleted Hematopoietic Stem Cells Transplantation in Children with Acute Leukemia

Targeting Bcl-2 and CD38 As Part of Personalized HSCT Conditioning Regimen in Chemorefractory Pediatric Leukemia

T Cell Repertoire after Alpha/Beta-T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients

Tcrαβ+/CD19+-Depletion in Hematopoietic Stem Cells Transplantation from Matched Unrelated and Haploidentical Donors Following Treosulfan or TBI-Based Conditioning in Pediatric Acute Lymphoblastic Leukemia Patients

Relapse Prediction By Flow Cytometric Minimal Residual Disease Assessment in Infants with Acute Lymphoblastic Leukemia

Transplantation from Matched Unrelated and Haploidentical Donor in Pediatric Severe Aplastic Anemia: Experience with TCR Alpha/Beta and CD19 Depletion As Graft Processing Method

Improved Control of GvHD with Rabbit ATG, Rituximab and Bortezomib Among Pediatric Leukemia Patients after Tcrαβ/CD19-Depletion of Transplant from Matched Unrelated and Haploidentical Family Donors: A Single-Center Retrospective Analysis of Two Gvhd-Prophylaxis Regimens

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only